20217248

Source:http://linkedlifedata.com/resource/pubmed/id/20217248

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0152018, umls-concept:C0205462, umls-concept:C0439165, umls-concept:C0600558, umls-concept:C0684321, umls-concept:C1182670, umls-concept:C1441322, umls-concept:C1514474, umls-concept:C1516048, umls-concept:C1559154, umls-concept:C1609982
pubmed:issue	8
pubmed:dateCreated	2010-7-8
pubmed:abstractText	Whether the TNM staging system is applicable after neoadjuvant chemoradiation in esophageal cancer is controversial. The aim of this study was to evaluate the prognostic value of histopathological regression of the primary tumor in postchemoradiated patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-10653860, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-11208820, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-11260097, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-11391598, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-11553217, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-12049861, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-12829133, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-12909224, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-1455880, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-14657432, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-15239237, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-15719440, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-15849517, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-16244542, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-16485154, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-16607651, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-17114016, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-17290058, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-17457163, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-8137201, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-8194005, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-8501498, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-8551792, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-8672151, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-9219702, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-9301446, http://linkedlifedata.com/resource/pubmed/commentcorrection/20217248-9869669
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9420840
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1534-4681
pubmed:author	pubmed-author:ChanKwok WahKW, pubmed-author:KwongDora Lai WanDL, pubmed-author:LamAlfred King YinAK, pubmed-author:LawSimonS, pubmed-author:TongDaniel King HungDK, pubmed-author:WongKam HoKH
pubmed:issnType	Electronic
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2184-92
pubmed:meshHeading	pubmed-meshheading:20217248-Adult, pubmed-meshheading:20217248-Aged, pubmed-meshheading:20217248-Aged, 80 and over, pubmed-meshheading:20217248-Carcinoma, Squamous Cell, pubmed-meshheading:20217248-Cell Survival, pubmed-meshheading:20217248-Chemotherapy, Adjuvant, pubmed-meshheading:20217248-Esophageal Neoplasms, pubmed-meshheading:20217248-Esophagectomy, pubmed-meshheading:20217248-Female, pubmed-meshheading:20217248-Humans, pubmed-meshheading:20217248-Lymph Nodes, pubmed-meshheading:20217248-Male, pubmed-meshheading:20217248-Middle Aged, pubmed-meshheading:20217248-Neoadjuvant Therapy, pubmed-meshheading:20217248-Neoplasm, Residual, pubmed-meshheading:20217248-Neoplasm Staging, pubmed-meshheading:20217248-Prognosis, pubmed-meshheading:20217248-Proportional Hazards Models, pubmed-meshheading:20217248-Prospective Studies, pubmed-meshheading:20217248-Radiotherapy, Adjuvant, pubmed-meshheading:20217248-Sex Factors, pubmed-meshheading:20217248-Survival Rate, pubmed-meshheading:20217248-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor.
pubmed:affiliation	Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
pubmed:publicationType	Journal Article, Evaluation Studies